Ovid Therapeutics Inc. ( OVID) - Key Metrics
OVID Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | $0.12 | -$0.13 | -$0.13 |
| 2025Q3 | $0 | -$0.17 | -$0.18 | -$0.18 |
| 2025Q2 | $0.09 | -$0.07 | -$0.07 | -$0.07 |
| 2025Q1 | $0 | -$0.14 | -$0.14 | -$0.14 |
OVID Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 3.44 |
| 2025Q3 | ? | -1.90 |
| 2025Q2 | ? | -1.25 |
| 2025Q1 | ? | -0.54 |
OVID
Price: $2.42
52 week price:
Earnings Per Share: -0.21 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 61100
Ebitda: -9.4 millionMarket Capitalization: 316.5 million